TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 54 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $12,660,000 | +4.7% | 13,285,000 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $12,095,000 | -1.0% | 13,285,000 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $12,214,000 | -0.8% | 13,285,000 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $12,314,000 | +2.1% | 13,285,000 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $12,056,000 | -3.5% | 13,285,000 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $12,491,000 | +0.9% | 13,285,000 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $12,380,000 | +5.7% | 13,285,000 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $11,710,000 | – | 13,285,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ZAZOVE ASSOCIATES LLC | 95,823,000 | $114,365,000 | 5.28% |
INCOME RESEARCH & MANAGEMENT | 12,056,000 | $14,384,000 | 2.34% |
AEGON USA Investment Management, LLC | 6,000,000 | $7,159,000 | 1.44% |
MACKAY SHIELDS LLC | 18,832,000 | $22,547,000 | 1.02% |
CSS LLC/IL | 14,850,000 | $17,728,000 | 0.86% |
SHENKMAN CAPITAL MANAGEMENT INC | 8,492,000 | $10,174,000 | 0.78% |
ADVENT CAPITAL MANAGEMENT /DE/ | 33,022,000 | $39,393,000 | 0.57% |
PALISADE CAPITAL MANAGEMENT, LP | 6,088,000 | $7,254,000 | 0.26% |
AXA S.A. | 34,000,000 | $40,566,000 | 0.18% |
SSI INVESTMENT MANAGEMENT LLC | 1,664,000 | $1,975,000 | 0.18% |